Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-12-10 00:00:00 ET · period of report 2024-12-06 · accession 0001883850-24-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-12-10 | 2024-04-04+ | REGN | Pitofsky Jason | VP Ctrl | G - Gift | $0.00 | +179 | 89 | New | $0 |
| D | 2024-12-10 | 2024-12-09 | REGN | Pitofsky Jason | VP Ctrl | F - Tax | $787.00 | -149 | 4,962 | -3% | -$117.3K |
| D | 2024-12-10 | 2024-12-06 | REGN | Pitofsky Jason | VP Ctrl | A - Grant | $0.00 | +907 | 5,111 | +22% | $0 |
| D | 2024-12-10 | 2024-12-06 | REGN | Pitofsky Jason | VP Ctrl | A - Grant | $0.00 | +3,236 | 3,236 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-29 | G | A | 90 | $0.00 | 179 | I | — | — | |
| 2 | Common | Common Stock | 2024-04-04 | G | A | 89 | $0.00 | 89 | I | — | — | |
| 3 | Common | Common Stock | 2024-12-09 | F | D | 149 | $787.00 | 4,962 | D By Trust | — | — | |
| 4 | Common | Common Stock | 2024-12-06 | A | A | 907 | $0.00 | 5,111 | D By Trust | — | — | |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-12-06 | A | A | 3,236 | $0.00 | 3,236 | D | $771.64 · — to 2034-12-06 | 3,236 Common Stock | (F2) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |